Beta · prototype— This site is under construction: rankings, texts and features change every week.

Infermedica

Active#9 in Poland

AI symptom triage

HealthTech›AI symptom triage
Founded2012
HQWrocław
RaisedUSD ~45M
Last roundSeries B · Jan 2022
Country of originPolandListed in the Poland ranking
Where would you invest?Poland (a US entity also exists)Jurisdiction as cited by the ranking

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Poland · all sectorsTop 15#9Edition 0 – beta · September 202615 Dec 2026
Rank historySep 2026 · #9First edition: no movements yet.

Estimated valuation

AI · Poland ranking
≈ USD 150MUSD 100–230M · Hundreds of M$ Medium confidence
Anchor
Last known equity round: Series B · USD 30M · Jan 2022
AI adjustment
None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

USD ~45M raised in total
DateRoundAmountTypeInvestorsSource
Jan 2022Series BUSD 30MEquityOne Peaktechcrunch.com

Rounds as cited by Uback’s rankings and their sources. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Infermedica as a PDF, on one of three angles only:

ValuationWhat is Infermedica worth?
Versus competitorsIs #9 the right rank?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication and never change the rank.

Comparable companies in Poland

Full Poland ranking →

Investors in Infermedica: One Peak

Sources. techcrunch.com

Last updated: Sep 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.